Remember, a green light isn't the same as an open road. Go break some eggs.
👀 The Read
The FDA Modernization Act isn’t what everyone thinks it is.
And no, you still can’t skip animal studies for your IND.
Since the FDA Modernization Act 2.0 passed, a version of this keeps coming up: animal testing is over, we can go straight to the clinic on organ-chips and models. The 2025 roadmap and the NAMs guidance made it louder.
But for a program planning IND-enabling studies right now, it's wrong.
Here's what the Act actually did. It changed the language — it removed the blanket federal mandate that every new drug be tested in animals, and it made non-animal methods (in vitro assays, organ-on-chip, in silico models) legally permissible as supporting data. That's a real change to what you're allowed to submit. It is not a change to what FDA will accept as sufficient to clear a drug for FIH.
The Act didn't alter FDA's evidentiary standards, and it didn't eliminate animal testing for anything reaching first-in-human. The early movement is real but narrow — the FDA is accepting non-animal methods in regulatory submissions but they are still requiring rodent/nonrodent nonclinical programs as the main justification of safety. In practice, GLP studies using animals are still necessary. Whether or not those packages are streamlined is based on the needs of the molecule, not the support of the FDA Modernization Act.
So the correct read isn't "animals are optional now." It's "non-animal data is now submittable alongside your animal studies — and someday, for validated contexts, may replace them." Plan your program on the first interpretation and you'll walk into a clinical hold defending organ-chip data FDA never agreed to accept in place of a tox study.
The Misconception: The FDA Modernization Act means you can skip animal studies for your IND.
The Correction: The Act made non-animal methods permissible to submit — it didn't make animal studies optional. "Permitted to submit" and "sufficient for FDA to accept" are different bars. For a routine IND-enabling program today, the tox package is essentially unchanged
🔎 Curious what you get in the Free Preview?
The Complete Guide to Nonclinical Development is a very comprehensive course, which is why I’ve setup a Free Preview to let you see what you’re getting into. The Free Preview gives you a snapshot of the inside of the course, with access to the Introduction and all of Module 1. Check out the videos, lessons, syllabus, workbooks and more.
A snapshot of what the inside of the course looks like → https://www.nonclinical.academy/